 |
Inspiring stakeholders to take action on antimicrobial resistance (AMR) starts with communicating the current and future burden of infection | |
 |
While many stakeholders are aware of the acute, life-threatening presentation of resistant infections, there is also a significant and under-appreciated burden of chronic stable or recurrent infections | |
 |
Taking a broader view provides opportunities to further emphasize the burden of AMR and improve the lives of patients with infectious diseases |
As with acute infections, new antibiotic options are key to addressing the needs of chronic infection patients
SOLUTIONS
- More commercial incentives*
- More investment
- More antibiotic options
IMPACTS
Acute and chronic patients more likely to have an effective therapy available
- Acute patients have better outcomes, can be discharged sooner and have a lower risk of becoming chronic/recurring
- Chronic patients have a lower risk of running out of options and may experience less frequent recurrences
However, we also need to engage stakeholders to improve awareness of all types of resistant infections and improve patient management
SOLUTIONS
- More stakeholder awareness of patient burden
- More research on patient experience
- More implementation of patient-centric management protocols
IMPACTS
Acute and chronic patients have more positive interactions with HCPs
- Acute patients can manage uncertainty, fear and isolation more effectively
- Chronic patients experience more coordinated care, and feel supported and informed
*For more information, see CRA infographic “Policy solutions to commercial challenges in the fight against Antimicrobial Resistance”
Source: Whittaker et al (2023). Global Public Health, 18(1); Hamilton et al (2024). Sci Rep 14
